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During the last decades, the share of population using prescription (Rx) medicines has considerably increased. With
the wider introduction of self-medication and the use of over-the-counter (OTC) medicines, there is a real threat
for drug-drug interactions between Rx and OTC medicines neither identified nor overseen by healthcare specialists.
The objectives of this survey were to ascertain how often, and for what conditions OTC and Rx medicines are used
simultaneously, and to discuss possible health hazards connected with the concomitant use of these medicines.
This survey was designed as a descriptive, cross-sectional questionnaire-based interview which was conducted
amongst pharmacy customers and patients in urban and rural areas of Estonia in between 2010–2012.
In total, 712 respondents participated in the survey. Of those, 50.4% reported concomitant use of Rx and OTC
medicines during the survey. The simultaneous use of Rx and OTC medicines increased with age and the number
of chronic diseases (both p < 0.001). Of chronic patients, 37.1% used Rx and OTC medicines on a daily basis over a
four-week period before the survey, and considering reported chronic diseases and the most widespread OTC
medicines, they could encounter drug-drug interactions between Rx medicines (e.g. antihypertensives, anti-inflammatory
medicines) and OTC medicines (e.g. paracetamol, NSAID-s, herbal medicines and adsorbents).
The present survey revealed frequent concomitant use of Rx and OTC medicines. Especially vulnerable are chronic and
elderly patients. In the future, both patients and healthcare specialists should pay more attention to possible drug-drug
interactions of Rx and OTC medicines.Introduction
The use of over-the-counter (OTC) medicines has in-
creased significantly in recent years (Amoako et al. 2003;
Goh et al. 2009), but despite the positive aspects, such as
improved availability of medicines, decreased number of
physicians’ visits for minor illnesses and self-limiting con-
ditions, and the increase of patients involvement in their
treatment, patients do not fully comprehend the risks
accompanying self-treatment, such as prolonged use,
wrong dosage, side effects, and possible drug-drug interac-
tions (Eickhoff et al. 2012). Patients consider OTC medi-
cines to be safe (Ngo et al. 2010; Wawruch et al. 2013)
and only regard their positive effects; therefore, they often
ignore patient information leaflets and base their use of* Correspondence: daisy.volmer@ut.ee
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reproduction in any medium, provided the origmedicines on prior experience (Cullen et al. 2006; Hanna
and Hughes 2011; Hughes et al. 2002; Wirtz et al. 2009).
Previous studies have confirmed that among the other
age groups, OTC medicines are purchased and more often
used by elderly patients (Sihvo et al. 2000) who frequently
have multiple comorbid diseases, and therefore use poly-
pharmacy. As a result, drug-drug interactions between
OTC and prescription medicines (Rx) may occur. While
patients are aware of possible drug-drug interactions
between Rx medicines, patient knowledge regarding inter-
actions between OTC and Rx medicines has not been well
studied, although the occurrence of the aforementioned
interactions has been described as frequent (Olesen et al.
2013; Sihvo et al. 2000).
Olesen et al. found that in Denmark, 50% of elderly
patients taking OTC medicines were exposed to poten-
tial interactions (Olesen et al. 2013); and Sihvo et al.
described that four percent of OTC users had takenr. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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nificant interactions (Sihvo et al. 2000). Based on this
knowledge, it is necessary to study the frequency of and
possible risks with the concomitant use of OTC and Rx
medicines in more detail.
The objectives of this research were:
– to ascertain how often and for what conditions
OTC and Rx medicines are used simultaneously,
according to self-assessment of Estonian
residents, and
– to discuss possible health hazards connected with
concomitant use of OTC and Rx medicines.
Materials and methods
Setting and survey sample
A questionnaire-based interview was conducted among
pharmacy customers and patients at five community
pharmacies and six general practitioner (GP) centres in
urban areas (Tallinn, Tartu and Narva) and in rural areas
(islands Saaremaa and Ruhnu) of Estonia in between
2010–2012. Depending on the region, the survey period
lasted four to six weeks. In the rural areas with lower
population density the study period was prolonged to six
weeks for reaching respective number of participants.
The interviews were performed on working days from
11:00 AM–17:00 PM. The vast majority of pharmacy
customers or patients aged between 15–85 years, purchas-
ing Rx or OTC medicine at a community pharmacy or ap-
proaching to registration desk at a GP centre were invited
to participate in survey. In all regions, the respondents
were interviewed by pharmacy students (in all regions one
pharmacy student per community pharmacy and one at
GP centre) who were previously trained to conduct inter-
views and respond to possible questions asked by cus-
tomers or patients. Respondents were informed about the
aims of the survey and their participation was voluntary.
Definitions of Rx and OTC medicines and chronic con-
ditions were provided only to those respondents who
required further guidance. Interviewing was performed in
a separate room or isolated section in sales area at com-
munity pharmacy or registration area at GP centre. The
average interviewing time was 10 minutes.
Face-to-face interviews in the form a pre-structured
questionnaire were selected to obtain more reliable
information. Trial period of the questionnaire demon-
strated insufficient knowledge of lay people about the
names of active components in OTC medicines, and a
self-administered questionnaire would have resulted in
incomplete replies or in the misinterpretation of items
that has also been experienced in earlier international
research (Cuzzolin and Benoni 2010).
The present research did not use identifiable human
material or data. The survey conforms to the Declarationof Helsinki and the ethical standards of Estonia. The
researchers have fulfilled the Data Protection Act of
Estonia.
Survey instrument
Survey instrument was developed by using the survey
models applied in our previous research on community
pharmacy services in Estonia, Estonian Health Interview
Survey, and on an Italian survey about the safety of OTC
medicines (Cuzzolin and Benoni 2010; Estonian Health
Interview Survey 2013; Volmer et al. 2009). The content
validity of the survey instrument was assessed by a panel
of researchers in social pharmacy, primary health care,
and pharmacy practice. The survey instrument was pilot
tested for face validity among a convenience sample of ten
pharmacy customers and patients. Based on the feedback,
minor changes were made to the wording of the items.
Overall, the structured survey instrument comprised of
17 mainly multiple-choice items related to the respon-
dents’ demographic background (age, gender, education,
region, and data collection location); their knowledge
about the use of OTC medicines for the treatment of
more common minor ailments (gastrointestinal tract and
respiratory tract disorders, minor skin complaints and
allergy, recurrent headache and other aches and pain),
and about concomitant use of OTC and Rx medicines
in the case of chronic diseases. To identify the simul-
taneous use of Rx and OTC medicines, respondents
were asked to indicate the use of Rx and/or OTC
medicines at the time of the survey and the frequency
of concomitant use of described medicines one month
prior to the survey.
In addition, respondents’ attitudes toward community
pharmacies as information sources about OTC medi-
cines were asked. The analyses outlined in this manu-
script relates only to the concomitant use of Rx and
OTC medicines.
In the current survey OTC medicines were defined as
non-prescription medicines, herbal medicines and diet-
ary supplements not licensed as prescription medicines
in Estonia. The respective information was received from
the register of authorised medicinal products at the State
Agency of Medicines.
Rx medicines were identified by means of the names
of chronic diseases where the use of Rx medicines is
consistent, as INN (International Nonproprietary Name)
and the trade names of Rx medicines were less familiar
to patients.
Chronic disease was defined as a human health condi-
tion or disease that is persistent for longer than three
months and cannot be prevented or treated by medicines.
In this survey people who were interviewed at commu-
nity pharmacy were defined as pharmacy customers and
those interviewed at GP centre as patients.
Table 1 Demographic characteristics of the respondents
(n = 712)













Primary/secondary school 327 45.9
Secondary school education with specialisation 220 30.9
University degree 165 23.2
Region
Urban area (Tartu, Tallinn,Narva) 533 74.9
Rural area (Saaremaa and Ruhnu) 179 25.1
Survey location
Pharmacy 363 51.0
GP centre 349 49.0
Chronic disease
Incidence of chronic disease with concomitant use
of Rx and OTC medicines
448 63.0
Incidence of chronic disease was not indicated 264 37.0
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Statistical analyses
For statistical analysis, IBM SPSS Statistics v. 19.0.0.2
was used. Cross tabulations and Chi Square tests and
Cramer’s V were employed to evaluate statistical correla-
tions between demographic data of the respondents and




In total, 712 individuals were interviewed during the
survey period. The number of patients/customers who
refused to participate in the study was not recorded. In
the survey, age distribution of the population was almost
equal and corresponded to the age groups of general
population in Estonia. However, 2/3 of the respondents
were females and from urban regions. More than half of
the respondents reported chronic disease with regular
use of Rx medicines and simultaneous use of OTC med-
icines for treatment of minor ailments (Table 1).
Chronic diseases and the use of Rx and OTC medicines
For identification of what Rx medicines respondents
have used concomitantly with OTC medicines survey
participants were asked to indicate their chronic disease(s)
require regular use of Rx medicines. More frequently listed
diseases and conditions included hypertension (n = 210),
recurrent headache and other aches and pain (n = 179),
arthritis and joint pain (n = 158), and other cardiovascular
diseases (n = 124) (Figure 1).
Concurrent use of OTC and Rx medicines
During the period when the survey was conducted,
20.2% (n = 144) of the respondents used only OTC med-
icines, 13.6% (n = 97) used only Rx medicines, and 50.4%
(n = 359) reported simultaneous use of both medicines
(Figure 2).
During the four weeks prior to the survey, 24.6%
(n = 175) of survey participants in total and 37.1%
(n = 264) of those suffered from at least one chronic
disease used Rx and OTC medicines simultaneously on a
daily basis. In different age groups, concomitant daily use
of Rx and OTC medicines increased from 12.5% in the
15–19 years group to 65.0% in the 70+ years group
(p < 0.001; Cramer’s V 0.23). The use of Rx and OTC
medicine was more frequent (p < 0.001; Cramer’s V 0.25)
with patients with an increased number (3–4) of chronic
diseases. In the comparison of urban and rural regions,
the concurrent daily use of Rx and OTC medicines was
slightly higher in rural areas (p < 0.001; Cramer’s V 0.17).The use of OTC medicines was studied in more detail
among those respondents who indicated chronic disease
and simultaneous use of Rx and OTC medicines. Figure 3
illustrates more frequently used OTC medicines in the
case of more prevalent chronic diseases or conditions
where the use of Rx medicines is mostly required. The
reported OTC medicines were mostly used for treatment
of minor complaints. While the top consisted mostly of
widely used OTC medicines containing NSAIDs (non-ster-
oidal anti-inflammatory drugs) and paracetamol, traditional
treatments (herbal medicines and adsorbents - charcoal)
were also popular (Figure 3). Last mentioned OTC medi-
cines were frequently used for relieving minor respiratory
and gastrointestinal tract complaints.
It was common to use 2–3 different OTC medicines
to cure one type of minor illnesses. However, the survey
instrument did not allow to determine, whether the dif-
ferent medicines were used simultaneously or not. When
respondents already showed the symptoms of a minor
illness, only a few of them used vitamin and/or mineral
preparations or probiotics to support the body during
Figure 1 Incidence of chronic diseases when the concurrent use of Rx and OTC medicines was indicated.
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illnesses in the future.
Discussion
This is the first survey among Estonian residents
describing the concomitant use of Rx and OTC medi-
cines. Several international surveys have previously
described possible risks in the use of Rx or OTC medi-
cines (Olesen et al. 2013; Sihvo et al. 2000). However,
there has been little interest in the description of clinical
hazards that could manifest in the interactions of Rx and
OTC medicines (Bond and Hannaford 2003).
Factors influencing identification of drug interactions
The results of the present survey do not describe the
impact of pharmaceutical policy to the identification and
evaluation of drug interactions. However, this knowledge
would serve as clarification to the reasons why drug
interactions occur and this process is not controlled by
healthcare specialists.
Estonia has been described as a good example of the
implementation of the Electronic Health Record (EHR).
As a part of this system, digital prescription was introducedFigure 2 The use of Rx and OTC medicines at the time of survey amo
disease.in 2010. Currently, GPs can follow the dispensing of
prescribed medicines but still miss information about OTC
medicines purchased independently by the patient. Drug
communication that takes place at the community phar-
macy is mainly connected with currently dispensed Rx or
OTC medicines as pharmacists have no access to patients’
medical records. On the other hand, community pharma-
cists could be well positioned health care specialists, who
evaluate the use of both Rx and OTC medicines, as in
Estonia the sale of OTC medicines is limited to pharma-
cies. In the current situation, it depends on the patients
whether they inform their GP about the use of OTC medi-
cines, and the pharmacist about Rx medicines, and
whether they receive evidence-based information concern-
ing possible interactions (Estonian EHR Case Study 2013;
Implementation of digital prescriptions in Estonia 2013).
Leemans et al. have stressed the accessibility of med-
ical records by pharmacists as an important factor in the
elimination of prescription errors, including the identifi-
cation of clinically important drug-drug interactions
(Leemans et al. 2003). However, other surveys describe
the situation where drug-drug interactions are a much
less discussed topic by both patients and communityng Estonian residents with chronic disease and without chronic
Figure 3 At the time of survey more frequently used OTC medicines by chronic patients with regular use of Rx medicines.
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administration and dosage (Cullen et al. 2006; Cuzzolin
and Benoni 2010; Hanna and Hughes 2011; Hughes
et al. 2002; Olesen et al. 2013; Sihvo et al. 2000; Volmer
et al. 2009; Wirtz et al. 2009).
Use and interactions of Rx and OTC medicines
This survey demonstrates the frequent use of Rx and
OTC medicines, and the results are in accordance with
previous research in Estonia. In between 1996–2006, the
use of Rx medicines increased by 61% (30.9% in 1996 to
49.8% in 2006), and the number of patients using two or
more prescription medicines simultaneously has doubled
(Volmer et al. 2012). Another survey stressed that ¼ of
the population in Estonia is using OTC medicines on a
daily or weekly basis and 2/3 has made the decision
independently without consulting a healthcare specialist
(Kiivet 2009).
Similarly to Rx medicines, clinically significant phar-
macokinetic and pharmacodynamic interactions might
occur between OTC and Rx medicines (Strandell and
Wahlin 2011). In this survey, ibuprofen and paracetamol
were the most frequently used OTC medicines, followed
by acetylsalicylic acid, and diclofenac (in doses 12.5 mg,
or locally) that the respondents had taken to alleviate
headaches, joint pain, and muscular pain. Nearly half of
ibuprofen users indicated hypertension as a chronic
comorbid condition; also, almost one-fourth of the re-
spondents who used acetylsalicylic acid and diclofenac
suffered from high blood pressure. The use of NSAIDs
concomitantly with hypertension medicines has also
been noted by other authors (Goh et al. 2009; Sihvo
et al. 2000). It should be borne in mind that NSAIDs
influence the effectiveness of antihypertensive medicines,
particularly β-blockers, but also ACE inhibitors (Angioten-
sin-converting-enzyme inhibitor), and ARBs (Angiotensin
receptor blocker), and the effect of loop diuretics could be
weakened (Aljadhey et al. 2012; Fournier et al. 2012). In
addition, long-term simultaneous use of ACE inhibitors
and ARBs with NSAIDs has been described to cause renal
impairment (Lapi et al. 2013). According to these findings,it is necessary to check patients’ blood pressure and renal
function on a regular basis.
Arthritis with pain syndrome was mentioned as another
chronic disease. Previous studies that have revealed that for
pain alleviation, patients quite often disregard the amount
of maximum doses – these are exceeded, or several differ-
ent NSAIDs are used simultaneously, which significantly
increases the risk of gastrointestinal and other adverse
effects (Cavagna et al. 2013; Hersh et al. 2007). Hence, to
avoid the exceeding of maximum daily dosages, healthcare
specialists should provide more extensive information
about drug-drug interactions and side effects.
As a particular finding of this survey, adsorbents (char-
coal tablets) and herbal medicines were frequently used by
patients with hypertension, arthritis, headaches, and other
type of pain to treat minor illnesses or complains. Char-
coal tablets have traditionally been used to relieve gastro-
intestinal tract discomfort (e.g. flatulence, diarrhea), and
in the case of minor intoxications (AACT and EAPCCT
1999; Bond 2002; Hall et al. 1981). The present survey
demonstrated that this tradition is still followed by many
chronic patients who perhaps due to ignorance affect the
absorption of other medicines, making it a problem that
has already been described in earlier research (Ibezim
et al. 1999).
In Estonia, herbal medicines have been reported as
frequently used preparations to treat the cold and flu
(Raal et al. 2013). The present survey revealed similar
results as chronic patients used herbal medicines mostly
for the treatment of minor respiratory tract ailments. Al-
though our survey did not specify in detail what herbal
medicines the respondents used, it should be mentioned
that some herbal medicines (St John’s wort, etc.) may
have a significant effect on the enzymatic activity of liver
cytochromes and therefore influence the effectiveness of
prescription medicines (Williamson 2003).
Limitations
This survey did not allow to determine possible interac-
tions of particular Rx medicines with OTC medicines.
The pilot period of the survey demonstrated insufficient
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and product names of OTC medicines. Consequently,
instead of using INN (International Nonproprietary
Name) and the trade names of Rx medicines, we decided
to use the names of chronic diseases people are more
familiar with to determine possible concomitant use of
Rx and OTC medicines.
Conclusion
The present survey highlighted the frequent use of Rx
and OTC medicines concurrently. OTC medicines have
been mostly used for self-treatment of minor illnesses.
Patients who self-administer OTC medicines and have
chronic diseases what require regular use of Rx medicines
may involuntarily influence the effects of used medicines.
Therefore, patients need to be constantly advised by health-
care professionals.
In the light of the current pharmaceutical policy in
Estonia, the quality of guidance can be improved if both
GPs and community pharmacists had access to patients’
overall medical record, which includes the history of using
both OTC and Rx medicines. It may be argued that the
access to a complete medication record is especially im-
portant for elderly patients, because side effects and drug-
drug interactions manifest often among this group.
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